<DOC>
	<DOCNO>NCT02035046</DOCNO>
	<brief_summary>Gitelman syndrome salt waste tubulopathy cause mutation SLC12A3 gene cod thiazide sensitive sodium chloride cotransporter . This disease mimic chronic treatment thiazide diuretic characterize renal hypokalemia , low normal blood pressure , hypocalciuria hypomagnesemia . The purpose study determine whether heterozygous carrier present metabolic risk and/or benefit disease .</brief_summary>
	<brief_title>Clinical Significance Heterozygosity Mutations SLC12A3 Gene Coding Thiazide Sensitive Na-Cl Cotransporter</brief_title>
	<detailed_description>Gitelman syndrome ( GS ) , autosomal recessive salt waste tubulopathy cause mainly loss function mutation SLC12A3 gene cod thiazide sensitive sodium-chloride cotransporter ( NCC ) . Thus , GS mimic chronic treatment high dos thiazide diuretic . NCC express distal convoluted tubule , responsible 7 % NaCl reabsorption . GS frequent hereditary tubulopathie estimate prevalence 1/40000 , implicate 1 % general population heterozygous carrier ( 600 000 France ) . Previous publication suggest apparently asymptomatic heterozygous carrier could present clinical trait GS chronic thiazide treatment . These include : beneficial aspect ( low blood pressure , low urinary calcium excretion ) metabolic risk ( hypokalemia , insulin resistance ) . Nevertheless , study evaluate aspect blood pressure evaluate hospital setting . This study aim compare home monitoring blood pressure ; salt balance ; potassium , glucose lipid mineral metabolism vascular function 80 heterozygous carrier , 80 GS patient 80 control person ( without mutation SLC12A3 gene ) .</detailed_description>
	<mesh_term>Gitelman Syndrome</mesh_term>
	<criteria>Gitelman syndrome patient , relative carry heterozygous mutation relatives healthy voluntarees without mutation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gitelman</keyword>
	<keyword>Heterozygous SLC12A3 mutation</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Hypokalemia</keyword>
</DOC>